Clorox (CLX) PT Lowered to $140 at Wells Fargo, 'Margin Pressures Build In FQ2, But Mgmt Stays The Course'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Clorox (CLX) PT Raised to $141 at Citi
February 7, 2018 6:23 AM ESTCiti raised its price target on Clorox (NYSE: CLX) to $141.00 (from $136.00) while maintaining a Neutral rating.
... MoreClorox (CLX) PT Lowered to $147 at BMO Capital
February 6, 2018 8:54 AM ESTBMO Capital lowered its price target on Clorox (NYSE: CLX) to $147.00 (from $150.00) while maintaining a Outperform rating.
... MoreClorox (CLX) PT Lowered to $133 at Morgan Stanley
February 5, 2018 7:36 AM ESTMorgan Stanley lowered its price target on Clorox (NYSE: CLX) to $133.00 (from $140.00) while maintaining a Equalweight rating.
... MoreClorox (CLX) PT Lowered to $137 at Deutsche Bank on 2Q Report; 'Challenged on the Margin... Near-Term Fundamental Pressures'
February 5, 2018 6:20 AM ESTDeutsche Bank lowered its price target on Clorox (NYSE: CLX) to $137.00 (from $158.00) while maintaining a Hold rating, following the company's second quarter 2018 earnings report.
Analyst Steve Powers notes a cautious outlook on the shares, as CLX reported second quarter revenue results below consensus... More
